MSD Korea, CJ to co-market Singulair

Published: 2009-09-25 06:58:00
Updated: 2009-09-25 06:58:00
CJ Cheil Jedang and MSD Korea announced on September 22 that the two companies have signed an agreement to co-market Singulair (montelukast sodium) in Korea.

Singulair is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older....

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.